相关实验视频
Updated: Jun 29, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
307
对PD-L1与PD-1和小分子的结合进行全面的计算洞察
Marialuigia Fantacuzzi1, Roberto Paciotti1, Mariangela Agamennone1
1Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, Via Dei Vestini, 31, 66100 Chieti, Italy.
Pharmaceuticals (Basel, Switzerland)
|March 28, 2024
概括
计算研究正在通过阐明小分子如何与PD-L1.1结合来彻底改变癌症免疫疗法. 这项研究有助于开发超越传统抗体的新型癌症药物.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
背景情况:
- 免疫疗法,特别是针对PD-1/PD-L1相互作用,已经改变了癌症治疗.
- 针对PD-1和PD-L1的单克隆抗体 (mAbs) 显示出临床前景,但存在局限性.
- 在疏水道中发现PD-L1的二元形式和连接体结合,刺激了对小分子抑制剂的兴趣.
研究的目的:
- 审查分析小分子与PD-L1.1的结合机制的计算研究.
- 了解计算方法在发现新的PD-L1配体中的作用.
- 探索与小分子结合有关的PD-L1二元化过程.
主要方法:
- 对PD-L1相互作用的基于结构的计算分析.
- 详细介绍PD-1/PD-L1和小分子配体的计算研究的文章的综述.
- 包含虚拟查研究,确定已验证的PD-L1配体.
主要成果:
- 计算研究提供了对小分子与PD-L1.1的结合机制的见解.
- 这些方法有助于阐明PD-L1二分化过程.
- 虚拟查已成功识别出潜在的PD-L1配体.
结论:
- 计算技术对于理解PD-L1结合和二分化至关重要.
- 这些方法在化学生物学和药物发现中发挥着越来越重要的作用.
- 这些发现支持开发用于癌症治疗的新型小分子抑制剂.
相关概念视频
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Protein-Drug Binding: Determination Methods
174
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
174
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K

